[{"uuid": "f1ca7f28-3919-3220-8b82-c084ecc68442", "title": "Daiwa Securities Adjusts Price Target on AbbVie to $190 From $180, Keeps Neutral Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/daiwa-securities-adjusts-price-target-134420835.html", "providerPublishTime": 1738676660, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "dc16941f-eeb4-3040-91d2-1450083b3888", "title": "Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/beyond-market-price-uncovering-abbvie-110142091.html", "providerPublishTime": 1738666902, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/odiIpiWq6hx5Y3dpe4hqMA--~B/aD0xNTA7dz0xNTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/6769769a69e907a6903be5e5994cebf3", "width": 150, "height": 150, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/CS0TIZRPI8SU.cmHgh7x4Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/6769769a69e907a6903be5e5994cebf3", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABBV"]}, {"uuid": "75b75d8f-441a-371a-83c4-46220a8ce9d1", "title": "Analysts reset AbbVie stock price target after earnings", "publisher": "TheStreet", "link": "https://finance.yahoo.com/m/75b75d8f-441a-371a-83c4-46220a8ce9d1/analysts-reset-abbvie-stock.html", "providerPublishTime": 1738686780, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/IlTYc2_DrK5xDaP1RNPj3A--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/2d33850084240e0e4752057fe18b610d", "width": 1200, "height": 675, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/IzXCpNoghOUeAzhLIAqhaw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet_881/2d33850084240e0e4752057fe18b610d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABBV"]}, {"uuid": "d4f41e92-07cc-3385-b7d5-2e4d137eed73", "title": "61-Year-Old Earning $130,000 in Dividends Shares Top 6 Stocks, Says 'Biggest Mistake' Was Holding Cash, Selling Stocks", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/61-old-earning-130-000-133018658.html", "providerPublishTime": 1738675818, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/gSSYgRSJLe30QSaZLFIy5w--~B/aD00ODA7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/e8052c952da0773de354dcf1b2fdaeb8", "width": 720, "height": 480, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/w_hJWfE6nyMcK.kHhe42XA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/benzinga_79/e8052c952da0773de354dcf1b2fdaeb8", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "88051f54-ad08-3a1b-bc1f-58f5be0eca59", "title": "UBS Adjusts Price Target on AbbVie to $190 From $181, Maintains Neutral Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/ubs-adjusts-price-target-abbvie-143512316.html", "providerPublishTime": 1738593312, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "abd9cc87-8270-3806-9717-39182be8841d", "title": "Truist Securities Adjusts AbbVie Price Target to $217 From $211, Maintains Buy Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/truist-securities-adjusts-abbvie-price-141817047.html", "providerPublishTime": 1738592297, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "ba98871c-f379-3761-a0c4-24b8b6bf0c6e", "title": "Deutsche Bank Adjusts AbbVie Price Target to $173 From $177, Maintains Hold Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/deutsche-bank-adjusts-abbvie-price-124241832.html", "providerPublishTime": 1738586561, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "06d50da4-3603-36a5-a76c-9f0d0fc67aee", "title": "Leerink Adjusts Price Target on AbbVie to $210 From $206, Maintains Outperform Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/leerink-adjusts-price-target-abbvie-120524702.html", "providerPublishTime": 1738584324, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "19d18a65-4162-329a-b6b7-23967ed587e9", "title": "Goldman Sachs Adjusts Price Target on AbbVie to $212 From $208, Keeps Buy Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/goldman-sachs-adjusts-price-target-114037066.html", "providerPublishTime": 1738582837, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "28bf56d8-8c48-30d9-8d1c-c662263b559b", "title": "Raymond James Adjusts Price Target on AbbVie to $220 From $218, Keeps Outperform Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/raymond-james-adjusts-price-target-113425750.html", "providerPublishTime": 1738582465, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "35a41097-121e-3081-852c-7f076131c186", "title": "Wolfe Research Adjusts Price Target on AbbVie to $220 From $205, Keeps Outperform Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/wolfe-research-adjusts-price-target-113407602.html", "providerPublishTime": 1738582447, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "9ae52cee-3a03-351a-b71e-62084d0139a4", "title": "Guggenheim Adjusts Price Target on AbbVie to $214 From $212, Keeps Buy Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/guggenheim-adjusts-price-target-abbvie-113438059.html", "providerPublishTime": 1738582478, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "7dfca29a-a6ff-3777-9c39-f8ed420afc43", "title": "Wells Fargo Adjusts Price Target on AbbVie to $210 From $195, Keeps Overweight Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/wells-fargo-adjusts-price-target-113415777.html", "providerPublishTime": 1738582455, "type": "STORY", "relatedTickers": ["ABBV"]}, {"uuid": "f3004d4f-0d4c-3ec9-ace9-eb940d4f82c0", "title": "Company News for Feb 3, 2025", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/company-news-feb-3-2025-142700434.html", "providerPublishTime": 1738592820, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/51tLtP3zn1cfamzFZS4A9Q--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/47a5c91ee32230c2f83ce3b58ad1263c", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Oiw3PNwHoIF8uoAOoKLDgw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/47a5c91ee32230c2f83ce3b58ad1263c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABBV", "CVX"]}, {"uuid": "e33e88fa-b767-3f18-a13f-e425528c3207", "title": "Health Care Stocks Rise After Trump Vows To 'Love and Cherish' Medicare, Medicaid", "publisher": "Investopedia", "link": "https://finance.yahoo.com/m/e33e88fa-b767-3f18-a13f-e425528c3207/health-care-stocks-rise-after.html", "providerPublishTime": 1738623274, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/RNqSmH8WJt9k1A3ECBli7g--~B/aD01MTUzO3c9NzcyNTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/investopedia_245/5f00164fa140bea48bf8d5c575985978", "width": 7725, "height": 5153, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/P7xOsKP8WIWo65kQqpYviw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/investopedia_245/5f00164fa140bea48bf8d5c575985978", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["^GSPC"]}, {"uuid": "6a2a6b92-d977-3470-9f68-ac193b342b13", "title": "S&P 500 Gains and Losses Today: Index Falls Following Tariff Announcements", "publisher": "Investopedia", "link": "https://finance.yahoo.com/m/6a2a6b92-d977-3470-9f68-ac193b342b13/s%26p-500-gains-and-losses.html", "providerPublishTime": 1738618950, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/FkRUGAYlWzrpDbNq037L.w--~B/aD0zMzUzO3c9NTAzMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/investopedia_245/cc6df586d051161ce3cdc9445122e309", "width": 5030, "height": 3353, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ySzf5oDsMiC7QPIKv9.fuA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/investopedia_245/cc6df586d051161ce3cdc9445122e309", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["^GSPC", "IDXX", "MRNA", "ABBV", "TSLA", "BEN", "FDX"]}, {"uuid": "f86c3c8b-b634-318b-a1c6-cb4dcf089520", "title": "Why AbbVie Inc. (ABBV) Is Among the Best Cancer Stocks to Buy According to Hedge Funds", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-abbvie-inc-abbv-among-211042384.html", "providerPublishTime": 1738530642, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/FoNkuu7lf_P.tZZeC8bUnA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/.J2tpXvJL_XbfUWkXjY_OQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/c554ad8e2af773e2e2a8438bfe2291ee", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABBV"]}, {"uuid": "40f55aab-1d97-393d-866b-c464a381e236", "title": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/why-investors-advantage-2-medical-140013479.html", "providerPublishTime": 1738591213, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Fj4TPQveJWuth16WIsEVAw--~B/aD01OTQ7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be", "width": 900, "height": 594, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/UfNPsRi0m54aItY_qLFDbg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ABBV", "INSP"]}, {"uuid": "d692d325-9bca-3533-8035-f1e9645382ec", "title": "Market Digest: SNY, BX, CLS, FL, GE, MSFT, NFG, SHEL, SYK, WBA, WM, WY, ABBV, BKR", "publisher": "Argus Research", "link": "https://finance.yahoo.com/m/d692d325-9bca-3533-8035-f1e9645382ec/market-digest%3A-sny%2C-bx%2C-cls%2C.html", "providerPublishTime": 1738584320, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/SVKRhvYIgdoUv2HlogaP.A--~B/aD0wO3c9MDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uc/fin/img/non-sub-report-thumb.png", "width": 0, "height": 0, "tag": "original"}]}, "relatedTickers": ["NFG", "WBA", "ABBV", "GE", "MSFT", "RYDAF", "SHEL", "WM", "CLS", "BKR", "WY", "BX", "FL", "SNY", "SNYNF", "SYK"]}, {"uuid": "64251520-76d5-325c-94f6-a8b638f7acad", "title": "Should You Invest in the SPDR S&P Biotech ETF (XBI)?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/invest-spdr-p-biotech-etf-112023920.html", "providerPublishTime": 1738581623, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83", "width": 900, "height": 633, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1wWgvR9AXA1o_EfTypadHw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83", "width": 140, "height": 140, "tag": "140x140"}]}}]